Lanxtra 1mg Tablet MD contains Lorazepam, a benzodiazepine class medication primarily indicated for the management of anxiety disorders, insomnia related to anxiety, and as a premedication for sedation prior to surgical or diagnostic procedures. Each tablet delivers 1mg of Lorazepam, which exerts its therapeutic effects by enhancing the activity of gamma-aminobutyric acid (GABA), an inhibitory neurotransmitter in the central nervous system, thereby producing anxiolytic, sedative, muscle relaxant, and anticonvulsant properties. Lanxtra is typically prescribed for short-term use due to the potential for tolerance, dependence, and withdrawal symptoms associated with prolonged administration. The onset of action is rapid, making it effective for acute anxiety episodes and procedural sedation. Dosage should be individualized based on patient response, age, and clinical condition, with caution advised in elderly patients and those with hepatic or renal impairment. Common adverse effects include drowsiness, dizziness, and impaired coordination, while serious side effects may involve respiratory depression and paradoxical reactions such as agitation or aggression. Lanxtra should not be combined with alcohol or other central nervous system depressants. It is contraindicated in patients with hypersensitivity to benzodiazepines, acute narrow-angle glaucoma, and severe respiratory insufficiency. Proper medical supervision is essential to minimize risks and ensure safe use.